Citigroup Initiates Coverage On Arrowhead Pharma with Buy Rating, Announces Price Target of $108
Benzinga Newsdesk 1 month ago
NewsInitiationAnalyst RatingsPrice Target
Citigroup analyst Eric Joseph initiates coverage on Arrowhead Pharma (NASDAQ:ARWR) with a Buy rating and announces Price Target of $108.
Citigroup analyst Eric Joseph initiates coverage on Arrowhead Pharma (NASDAQ:ARWR) with a Buy rating and announces Price Target of $108.